These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

131 related items for PubMed ID: 7526411

  • 21. [Growth and radiosensitivity of pulmonary micrometastases in the R1H-tumor of the rat].
    Raabe A, Beck-Bornholdt HP.
    Strahlenther Onkol; 1994 Feb; 170(2):111-5. PubMed ID: 8108777
    [Abstract] [Full Text] [Related]

  • 22. The influence of irradiation of the tumor bed on tumor hypoxia: measurements by radiation response, oxygen electrodes, and nitroimidazole binding.
    Kim IH, Lemmon MJ, Brown JM.
    Radiat Res; 1993 Sep; 135(3):411-7. PubMed ID: 8378534
    [Abstract] [Full Text] [Related]

  • 23. Vascular and cellular damage in a murine tumour during fractionated treatment with radiation and hyperthermia.
    Zywietz F.
    Strahlenther Onkol; 1990 Jul; 166(7):493-501. PubMed ID: 2382213
    [Abstract] [Full Text] [Related]

  • 24. Radiotherapy of the rhabdomyosarcoma R1H of the rat: postoperative radiotherapy.
    Carl UM, Beck-Bornholdt HP, Baumann M, Lorenzen J, Vogler H.
    Int J Radiat Oncol Biol Phys; 1990 Apr; 18(4):883-6. PubMed ID: 2323976
    [Abstract] [Full Text] [Related]

  • 25. Complete inhibition of rhabdomyosarcoma xenograft growth and neovascularization requires blockade of both tumor and host vascular endothelial growth factor.
    Gerber HP, Kowalski J, Sherman D, Eberhard DA, Ferrara N.
    Cancer Res; 2000 Nov 15; 60(22):6253-8. PubMed ID: 11103779
    [Abstract] [Full Text] [Related]

  • 26. Radiotherapy of the rhabdomyosarcoma R1H of the rat: hyperfractionation--126 fractions applied within 6 weeks.
    Beck-Bornholdt HP, Maurer T, Becker S, Omniczynski M, Vogler H, Würschmidt F.
    Int J Radiat Oncol Biol Phys; 1989 Mar 15; 16(3):701-5. PubMed ID: 2921168
    [Abstract] [Full Text] [Related]

  • 27. Dose rate dependence of the relative biological effectiveness of 103Pd for continuous low dose rate irradiation of BA1112 rhabdomyosarcoma cells in vitro relative to acute exposures.
    Nath R, Bongiorni P, Chen Z, Gragnano J, Rockwell S.
    Int J Radiat Biol; 2005 Sep 15; 81(9):689-99. PubMed ID: 16368647
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Evidence that Cereport's ability to increase permeability of rat gliomas is dependent upon extent of tumor growth: implications for treating newly emerging tumor colonies.
    Bartus RT, Snodgrass P, Dean RL, Kordower JH, Emerich DF.
    Exp Neurol; 2000 Jan 15; 161(1):234-44. PubMed ID: 10683290
    [Abstract] [Full Text] [Related]

  • 30. Effects of selenium on radiation responses of tumor cells and tissue.
    Dörr W.
    Strahlenther Onkol; 2006 Dec 15; 182(12):693-5. PubMed ID: 17149574
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Microvascular and tumor cell alterations during continuous hyperfractionated irradiation: an electron microscopic investigation on the rat R1H rhabdomyosarcoma.
    Lorke DE, Wenzel S, Siebert K, Zywietz F.
    Int J Radiat Oncol Biol Phys; 1999 Jul 01; 44(4):895-904. PubMed ID: 10386648
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Optimization of radiation controlled gene expression by adenoviral vectors in vitro.
    Anton M, Gomaa IE, von Lukowicz T, Molls M, Gansbacher B, Würschmidt F.
    Cancer Gene Ther; 2005 Jul 01; 12(7):640-6. PubMed ID: 15803145
    [Abstract] [Full Text] [Related]

  • 35. Radiobiological determination of growth kinetics and radiosensitivity of pulmonary micrometastases of the R1H tumour.
    Raabe A, Beck-Bornholdt HP.
    Radiother Oncol; 1994 Mar 01; 30(3):254-62. PubMed ID: 8209010
    [Abstract] [Full Text] [Related]

  • 36. Modulation of tumor angiogenesis by conditional expression of fibroblast growth factor-2 affects early but not established tumors.
    Giavazzi R, Giuliani R, Coltrini D, Bani MR, Ferri C, Sennino B, Tosatti MP, Stoppacciaro A, Presta M.
    Cancer Res; 2001 Jan 01; 61(1):309-17. PubMed ID: 11196179
    [Abstract] [Full Text] [Related]

  • 37. Inhibitory effects of somatostatin analogue RC-160 and bombesin/gastrin-releasing peptide antagonist RC-3095 on the growth of the androgen-independent Dunning R-3327-AT-1 rat prostate cancer.
    Pinski J, Reile H, Halmos G, Groot K, Schally AV.
    Cancer Res; 1994 Jan 01; 54(1):169-74. PubMed ID: 7903203
    [Abstract] [Full Text] [Related]

  • 38. Combined modality treatment of the rhabdomyosarcoma R1H of the rat: influence of sequence of cisplatin and fractionated irradiation.
    Würschmidt F.
    Int J Radiat Oncol Biol Phys; 1993 Jan 01; 25(1):73-8. PubMed ID: 8416884
    [Abstract] [Full Text] [Related]

  • 39. Initially accelerated fractionation of the R1H tumor of the rat increases local tumor control and might reduce impact of overall treatment time.
    Raabe A, Petersen C, Krüll A.
    Strahlenther Onkol; 2007 Jul 01; 183(7):360-5. PubMed ID: 17609868
    [Abstract] [Full Text] [Related]

  • 40. [The experimental brachytherapy of rhabdomyosarcoma R1H in the rat with iodine-125 seeds].
    Fassbender T, Beck-Bornholdt HP.
    Strahlenther Onkol; 1992 Jan 01; 168(1):48-52. PubMed ID: 1734592
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.